BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 17157472)

  • 1. Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinoma.
    Preuss SF; Klussmann JP; Wittekindt C; Damm M; Semrau R; Drebber U; Guntinas-Lichius O
    Eur J Surg Oncol; 2007 Apr; 33(3):358-63. PubMed ID: 17157472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
    Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR
    Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
    Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
    Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
    Dietl B; Marienhagen J; Schäfer C; Kölbl O
    Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes.
    Andruchow JL; Veness MJ; Morgan GJ; Gao K; Clifford A; Shannon KF; Poulsen M; Kenny L; Palme CE; Gullane P; Morris C; Mendenhall WM; Patel KN; Shah JP; O'Brien CJ
    Cancer; 2006 Mar; 106(5):1078-83. PubMed ID: 16444748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
    van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
    Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.
    Veness MJ; Morgan GJ; Palme CE; Gebski V
    Laryngoscope; 2005 May; 115(5):870-5. PubMed ID: 15867656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
    Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
    Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy.
    Doweck I; Denys D; Robbins KT
    Laryngoscope; 2002 Oct; 112(10):1742-9. PubMed ID: 12368607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of treatment for advanced cervical metastatic squamous cell carcinoma.
    Clark J; Li W; Smith G; Shannon K; Clifford A; McNeil E; Gao K; Jackson M; Mo Tin M; O'Brien C
    Head Neck; 2005 Feb; 27(2):87-94. PubMed ID: 15627246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes.
    Hinerman RW; Indelicato DJ; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Kirwan J; Mendenhall WM
    Laryngoscope; 2008 Nov; 118(11):1989-96. PubMed ID: 18849863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx.
    Moncrieff M; Sandilla J; Clark J; Clifford A; Shannon K; Gao K; O'Brien C
    Laryngoscope; 2009 Feb; 119(2):307-11. PubMed ID: 19172611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
    Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience.
    Preuss SF; Dinh V; Klussmann JP; Semrau R; Mueller RP; Guntinas-Lichius O
    Oral Oncol; 2007 Apr; 43(4):402-7. PubMed ID: 17071133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
    Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
    Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative radiotherapy for primary mucosal melanoma of the head and neck.
    Temam S; Mamelle G; Marandas P; Wibault P; Avril MF; Janot F; Julieron M; Schwaab G; Luboinski B
    Cancer; 2005 Jan; 103(2):313-9. PubMed ID: 15578718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: the outcome after combined-modality therapy.
    Boscolo-Rizzo P; Gava A; Da Mosto MC
    Ann Surg Oncol; 2007 May; 14(5):1575-82. PubMed ID: 17508250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.